Quality of life following laparoscopic Nissen fundoplication: Assessing short-term and long-term outcomes by Kellokumpu, Ilmo et al.
Quality of life following laparoscopic Nissen fundoplication: 
Assessing short-term and long-term outcomes
Ilmo Kellokumpu, Markku Voutilainen, Caj Haglund, Martti Färkkilä, Peter J Roberts, Hannu Kautiainen
Ilmo Kellokumpu, Department of Surgery, Central Hospital of 
Central Finland, 40620 Jyväskylä, Finland
Markku Voutilainen, Department of Gastroenterology, Central 
Hospital of Central Finland, 40620 Jyväskylä, Finland
Caj Haglund, Department of Surgery, Helsinki University Cen-
tral Hospital, 00029 Helsinki, Finland
Martti Färkkilä, Division of Gastroenterology, Department of 
Internal Medicine, Helsinki University Central Hospital, 00029 
Helsinki, Finland
Peter J Roberts, Department of Surgery, Turku University Hos-
pital, 20520 Turku, Finland
Hannu Kautiainen, Biostatistician, Unit of Primary Health Care, 
Helsinki University Hospital, 00029 Helsinki, Finland 
Hannu Kautiainen, Department of General Practice, Primary 
Health Care Unit, Turku University Hospital, 20520 Turku, Finland
Author contributions: All authors contributed equally to this 
work and participated to the design of the study, data acquisition, 
analysis and writing of the manuscript; all authors approved the 
final manuscript.
Supported by EVO-funding of the Central Hospital of Central 
Finland
Correspondence to: Ilmo Kellokumpu, MD, PhD, Chief, 
Department of Surgery, Central Hospital of Central Finland, Kes-
kussairaalantie 19, 40620 Jyväskylä, 
Finland. ilmo.kellokumpu@ksshp.fi
Telephone: +358-14-2691811  Fax: +358-14-2692929
Received: January 3, 2013        Revised: March 31, 2013
Accepted: April 9, 2013
Published online: June 28, 2013
Abstract
AIM: To investigate the quality of life following lapa-
roscopic Nissen fundoplication by assessing short-term 
and long-term outcomes.
METHODS: From 1992 to 2005, 249 patients under-
went laparoscopic Nissen fundoplication. Short-term 
outcome data including symptom response, side effects 
of surgery, endoscopy, and patient’s perception of over-
all success were collected prospectively. Long-term out-
comes were investigated retrospectively in patients with 
a median follow-up of 10 years by assessment of reflux 
symptoms, side effects of surgery, durability of antire-
flux surgery, need for additional treatment, patient’s 
perception of success, and quality of life. Antireflux sur-
gery was considered a failure based on the following 
criteria: moderate to severe heartburn or regurgitation; 
moderate to severe dysphagia reported in combination 
with heartburn or regurgitation; regular proton pump 
inhibitor medication use; endoscopic evidence of erosive 
esophagitis Savary-Miller grade 1-4; pathological 24-h 
pH monitoring; or necessity to undergo an additional 
surgery. The main outcome measures were short- and 
long-term cure rates and quality of life, with patient sat-
isfaction as a secondary outcome measure.
RESULTS: Conversion from laparoscopy to open sur-
gery was necessary in 2.4% of patients. Mortality 
was zero and the 30-d morbidity was 7.6% (95%CI: 
4.7%-11.7%). The median postoperative hospital 
stay was 2 d [interquartile range (IQR) 2-3 d]. Two 
hundred and forty-seven patients were interviewed 
for short-term analysis following endoscopy. Gastro-
esophageal reflux disease was cured in 98.4% (95%CI: 
95.9%-99.6%) of patients three months after surgery. 
New-onset dysphagia was encountered postoperatively 
in 13 patients (6.7%); 95% reported that the outcome 
was better after antireflux surgery than with preopera-
tive medical treatment. One hundred and thirty-nine 
patients with a median follow-up of 10.2 years (IQR 
7.2-11.6 years) were available for a long-term evalu-
ation. Cumulative long-term cure rates were 87.7% 
(81.0%-92.2%) at 5 years and 72.9% (64.0%-79.9%) 
at 10 years. Gastrointestinal symptom rating scores 
and RAND-36 quality of life scores of patients with 
treatment success were similar to those of the general 
population but significantly lower in those with failed 
antireflux surgery. Of the patients available for long-
term follow-up, 83% rated their operation a success.
CONCLUSION: For the long-term, our results indicate 
decreasing effectiveness of laparoscopic antireflux 
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surgery, although most of the patients seem to have 
an overall quality of life similar to that of the general 
population.
© 2013 Baishideng. All rights reserved.
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Core tip: Current evidence suggests that laparoscopic 
fundoplication is more effective than medical therapy 
for the short- and medium-term treatment of gastro-
esophageal reflux disease. This study examined short-
term and long-term outcomes after laparoscopic Nissen 
fundoplication. Short-term outcomes were assessed by 
symptom response, side effects of surgery, endoscopy 
and the patient’s perception of overall success. Long-
term outcomes were examined by addressing multiple 
domains affected by the operation including reflux 
symptoms, side effects of surgery, durability of antireflux 
surgery, selective objective testing, need for additional 
medical or surgical treatment, the patient’s perception 
of overall success, and long-term quality of life.
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INTRODUCTION
Medical treatment with proton pump inhibitors (PPIs) 
heals esophagitis and suppresses heartburn in over 90% 
of  patients[1-3]. Despite the fact that effective mainte-
nance therapies do exist, patients often require lifelong 
medication, and compliance with long-term maintenance 
therapy is sometimes difficult to achieve[1-3]. Furthermore, 
concerns exist regarding long-term safety of  PPI medi-
cation[4]. Current evidence suggests that laparoscopic 
fundoplication is more effective than medical therapy for 
the short- and medium-term treatment of  gastroesopha-
geal reflux disease[5-10]. In contrast to medical therapy that 
inhibits only acid reflux, antireflux surgery is designed to 
prevent reflux of  all gastric content. This is achieved by 
creating a mechanical antireflux valve that increases lower 
esophageal sphincter pressure and markedly reduces the 
rate of  spontaneous transient relaxations accompanied by 
reflux[11,12]. Side effects of  Nissen fundoplication such as 
dysphagia, increased bloating and flatulence, and inabil-
ity to belch or vomit may limit the success of  antireflux 
surgery[12,13]. Patients may also need revision surgery to 
improve symptom control, or revert to the use of  long-
term medical therapy following recurrent symptoms.
Optimal management of  chronic gastroesophageal 
reflux disease is uncertain as treatment options include 
either modern medical therapy using proton pump in-
hibitors or antireflux surgery[5]. In addition, long-term 
quality of  life studies are limited. This study examined 
short-term and long-term outcomes after laparoscopic 
Nissen fundoplication. Short-term outcomes were as-
sessed by symptom response, side effects of  surgery, en-
doscopy and the patient’s perception of  overall success. 
Long-term outcomes were examined by addressing mul-
tiple domains affected by the operation including reflux 
symptoms, side effects of  surgery, durability of  antireflux 
surgery, selective objective testing, need for additional 
medical or surgical treatment, the patient’s perception of  
overall success, and long-term quality of  life.
MATERIALS AND METHODS
Study population
From 1992 to 2005, a total of  249 patients underwent 
laparoscopic Nissen fundoplication for gastroesophageal 
reflux disease at the fourth Department of  Surgery, Hel-
sinki University Central Hospital (120 operations done by 
three surgeons: Kellokumpu I, Haglund C and Roberts PJ 
from 1992 to 1997) and at the Central Hospital of  Cen-
tral Finland (129 operations done by Kellokumpu I from 
1998 to 2005). Indications for antireflux surgery were re-
sidual symptoms while on medical therapy or endoscopic 
esophagitis after at least three months of  intensive acid 
suppression therapy, or both; dependence on continuous 
medication and expenses; and pathological 24-h esopha-
geal pH monitoring in symptomatic patients without 
preoperative endoscopic signs of  erosive esophagitis. 
Diagnosis of  gastroesophageal reflux disease was based 
on upper gastrointestinal endoscopy on 24-h ambulatory 
pH measurement according to standard criteria as estab-
lished by Johnson et al[14], and on esophageal manometry 
to evaluate the lower esophageal resting pressure and pre-
existing motility disorders[15]. Antisecretory medication 
was halted 7 d before assessment of  esophageal function. 
Preoperative and short-term outcome data were entered 
in a prospective database. Long-term outcome data were 
collected retrospectively.
Surgical technique
Laparoscopic floppy Nissen fundoplication was per-
formed by the standard 5-trocar technique as described[16]. 
Every patient had prophylactic anticoagulation and 
compressive elastic stockings. The fundus was routinely 
mobilized by ligating and dividing the short gastric ves-
sels (Kellokumpu I and Haglund C)[16]. The Rossetti-Hell 
modification[17] with mobilization of  the fundus posteri-
orly to the upper pole of  the spleen without division of  
short gastric vessels was preferred by Roberts PJ. A short 
(20 mm) fundic wrap was constructed around the distal 
esophagus with 2-0 non-absorbable sutures. Nasogastric 
tubes (18 F) and bougies (36 F) allowed calibration of  the 
fundic wrap and closure of  the hiatus. A posterior hiato-
plasty was performed with 2-0 non-absorbable stitches 
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when the esophageal hiatus was enlarged. The left side of  
the wrap was anchored to the cardia with an additional 1-2 
sutures. A nasogastric tube was left in place until the fol-
lowing morning when intake of  liquids was started. Solid 
intake was usually started on the second or third post-
operative day. All patients received dietary instructions 
before their discharge.
Evaluation of short-term outcomes
Preoperative and short-term symptom assessment three 
months after surgery was based on a standardized ques-
tionnaire and interview about heartburn, regurgitation, 
and dysphagia according to the DeMeester-Johnson re-
flux scale[18]. Regurgitation was graded as: none = 0, mild 
= 1 (occasional after straining, large meal, or lying down), 
moderate = 2 (predictable with position change, strain-
ing, or lying down), severe = 3 (history of  aspiration). 
Heartburn grades were none = 0, mild = 1 (recognizable 
symptom, no prior history of  medical treatment), moder-
ate = 2 (primary reason for medical visit or medical prob-
lem), severe = 3 (constant, marked disability in activities 
of  daily living). Dysphagia grades were none = 0, mild = 
1 (occasional with coarse foods), moderate = 2 (require 
liquids to clear), severe = 3 (history of  meat impaction 
necessitating medical attention)[18]. In addition, the fre-
quency of  heartburn, regurgitation and dysphagia was 
rated as absent = 0, occasional (less than once every two 
weeks) as 1, frequent symptoms (more than once every 
two weeks but less than daily) as 2, and daily symptoms (at 
least one attack/day to constant symptoms) as 3[19].
Side effects of  surgery such as disturbed belching 
ability, bloating (defined as abdominal swelling), and 
flatulence were analyzed with the patients assessing their 
degree of  disturbance by any postoperative decrease 
(belching) or increase (flatus, bloating) on a scale where 0 
= no change, 1 = mild change, 2 = moderate change, and 
3 = severe change.
Upper gastrointestinal endoscopy was routinely per-
formed preoperatively and at three months after surgery. 
Endoscopic classification of  esophagitis was based on the 
modified Savary-Miller 5-grade classification[20]. The state 
and localization of  the fundic wrap and the presence of  
paraesophageal hernia were checked postoperatively.
Overall short-term success of  the operation was as-
sessed by the patient’s subjective perception of  the out-
come after surgery compared to that with medical therapy 
and patient’s willingness to undergo surgery again for 
similar preoperative conditions. 
Evaluation of long-term outcome
Long-term outcome was investigated in a subgroup of  
patients with a median follow-up of  10 years and was 
based on the same self-completed, standardized question-
naire about heartburn, regurgitation, and dysphagia[18,19], 
and side effects of  surgery as in the short-term. Patients 
also reported time to symptom recurrence and the use of  
PPI medication as well as the date of  any re-fundoplica-
tion. Finally, long-term outcome of  surgery was assessed 
by a self-rated 7-point Likert scale describing outcome 
as good as expected (0), mildly (+1), moderately (+2) or 
markedly (+3) better or worse as -1, -2, -3 than expected 
and by willingness to undergo surgery again under similar 
preoperative conditions. During the long-term follow-up, 
objective testing including upper gastrointestinal endos-
copy, barium examination, and esophageal function stud-
ies was not routinely performed. 
Long-term quality of  life assessment was done by the 
self-completed Gastrointestinal Symptom Rating Scale 
(GSRS)[21,22], and overall quality of  life by RAND-36 
(SF-36)[23,24]. The GSRS is a disease-specific instrument 
comprising 15 items, each rated on a 7-point Likert scale 
from no discomfort to very severe discomfort, and fur-
ther divided into five dimensions: abdominal pain syn-
drome (abdominal pain, hunger pain and nausea), reflux 
syndrome (heartburn and acid regurgitation), diarrhea 
syndrome (diarrhea, loose stools and urgent need for def-
ecation), indigestion syndrome (borborygmus, abdominal 
distension, eructation and increased flatus), and constipa-
tion syndrome (constipation, hard stools and feeling of  
incomplete evacuation). The higher the GSRS score, the 
more the patient suffers from gastrointestinal symptoms. 
The Finnish RAND-36[23] covers eight areas of  health 
status, including physical functioning, role limitation due 
to physical health problems, bodily pain, general health, 
energy, social functioning, role limitation due to personal 
emotional problems, and emotional well-being. The raw 
responses were recoded according to the original version 
of  the RAND-36, each item being scored on a 0-to-100 
scale with higher scores indicating better quality of  
life[23,24]. Questionnaires were sent to the patients in May 
2006 and returned by November 2006. Incomplete an-
swers were completed by telephone interview.
Definition of failed antireflux surgery
Consistent with Lundell et al[25], laparoscopic Nissen fun-
doplication was considered failed if  at least one of  the 
following criteria was present: persistence or recurrence 
of  moderate to severe heartburn or regurgitation[18] oc-
curring more than once every two weeks (grade 2) or 
daily (grade 3)[19] or both; moderate to severe dysphagia[18] 
reported in combination with heartburn or regurgita-
tion or both; the use of  daily or weekly PPI medication; 
endoscopic evidence of  erosive esophagitis Savary-Miller 
grade 1-4; pathological 24-h pH monitoring; and neces-
sity to undergo redo surgery.
Ethics
The Central Hospital of  Central Finland ethics commit-
tee approved this study (K-Sshp Dnro 47/2005). The 
causes of  death were obtained from the National Cause 
of  Death Registry.
Statistical analysis
The data are presented as mean ± SD, as median with 
interquartile range (IQR), or as counts with percentages. 
The 95%CIs are given for the most important outcomes. 
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another patient with esophageal stricture were suture-
repaired and covered by the fundic wrap. A small fundic 
perforation caused by Harmonic scissors-induced ther-
mal injury occurred postoperatively in one patient and 
necessitated a laparotomy and suture repair. Overall, 30-d 
morbidity was 7.6% (95%CI: 4.7-11.7) (Table 2). Pleural 
empyema in one patient with esophageal injury neces-
sitated a thoracotomy and decortication. Comparing the 
two treatment centers and time periods, 30-d morbidity 
was similar (10.0% vs 5.4%, P = 0.17), but operation time 
[median 135 min (IQR 116.3-180 min) vs 75 min (IQR 
65-90 min), P < 0.001] and postoperative hospital stay 
[median 3 d (IQR 2-4 d) vs 2 d (IQR 1-2 d), P < 0.001] 
were shorter during the latter period.
Short-term outcomes 
Two of  the 249 operated patients could not be contacted 
3 mo after surgery, leaving 247 patients for short-term 
analysis. Based on symptom control and endoscopically-
verified healing of  erosive esophagitis, gastroesophageal 
reflux disease was cured in 243 of  the 247 patients [98.4% 
(95%CI: 95.9%-99.6%)]. Only four patients reported 
short-term failures. Two had persisting reflux symptoms 
and erosive esophagitis (grade 2) with partly disrupted 
plication. One had erosive esophagitis (grade 1) and too 
distally placed and partly disrupted plication. Another 
one who had an apparently normal fundoplication had 
persistence of  erosive esophagitis (grade 1). Three pa-
tients underwent a reoperation, and one was treated with 
Groups were compared using the Mann-Whitney U test 
or the χ 2 test. The statistical significance between groups 
in HRQL measures was evaluated by bootstrap-type 
analysis of  co-variance because of  the violation of  distri-
bution assumptions. Repeated measures for dichotomous 
outcomes were analyzed by Cochran’s Q test and the 
marginal homogeneity test. Time-to-failure analysis was 
based on the product limit estimate (Kaplan-Meier) of  
the cumulative “survival” function. The Finnish general 
population values[23] for the eight Rand-36 domains were 
weighted to match the gender- and age-distribution of  
the study population. Statistical analyses were performed 
with Stata statistical software, release 12.1 (StataCorp, 
College Station, TX, United States).
RESULTS
Baseline clinical characteristics of  the study population 
are shown in Table 1. Esophageal dilatations up to 18 mm 
in diameter were performed preoperatively in three of  
the four patients having esophageal stricture. Frequent 
or daily heartburn in 89.9% and regurgitation in 87.2% 
of  the patients were the main presenting symptoms. 
DeMeester-Johnson severity grades are shown in Table 1, 
and operative data and surgical outcome in Table 2. 
While major intraoperative complications occurred in 
three patients, no deaths occurred. A distal esophageal 
perforation caused by diathermy scissors in one patient 
and by an inadvertent push of  the calibration tube in 
  Follow-up Study population (n  = 249) Long-term (n  = 139)
  Age, yr (mean ± SD)                      51.2 ± 11.2              51.5 ± 10.6
  Sex, male/female                        131/118                 76/62
  ASA classification
     Ⅰ                        130 (52.0)                 85 (61.2)
     Ⅱ                          96 (38.4)                 40 (28.8)
     Ⅲ                          23 (9.2)                 14 (10.1)
  Duration of GERD in years, median (IQR)                            6 (5.0-10.0)                   6 (4.0-10.0)
  Preoperative medication
     PPI                        222 (89.2)               120 (86.3)
     H2-antagonist and/or prokinetic                          27 (10.8)                 19 (13.7)
  Duration of medical treatment, mo, median (IQR)                          18 (8.0-36.0)                 18 (6.0-36.0)
  Preoperative Helicobacter pylori eradication                          36 (14.6)                 20 (14.4)
  Preoperative symptom severity grade 1/2/3 as %1
     Heartburn                            0/49.8/48.6                   0/55.4/42.4
     Regurgitation                            5.6/87.6/4.4                   5.0/89.2/4.3
     Dysphagia                          12.0/9.2/0                 12.9/11.5/0
  pH < 4 of total time, median (IQR) as %2                          12.0 (8.0-18.7)                 11.5 (7.4-19.1)
  DeMeester score, median (IQR)                          42.5 (28.4-71.3)                 41.0 (26.2-69.3)
  Lower esophageal sphincter pressure in mmHg3, median (IQR)                          11.0 (8.0-16.0)                 11.0 (7.5-17.0)
  Preoperative grading of esophagitis (Savary-Miller)
     None                          68 (27.3)                 36 (25.9)
     Grade 1 (single erosive lesion, one longitudinal fold)                          22 (8.8)                 16 (11.5)
     Grade 2 (multiple erosive lesions, more than one fold)                          98 (39.4)                 57 (41.0)
     Grade 3 (circumferential lesions)                          13 (5.2)                   3 (2.2)
     Grade 4 (chronic ulcer or stricture ± Gr. 1-3)4                            5 (2.0)                   3 (2.2)
     Grade 5 (Barrett’s esophagus ± Gr. 1-3)                          43 (17.3)5                 24 (17.2)6
Table 1  Baseline clinical characteristics  n  (%)
1DeMeester et al[18]; 224-h pH monitoring in 232 patients; 3Esophageal manometry in 228 patients; 4Grade 4 (4 strictures, 1 ulcer); 5Barrett’s esophagus only 18 
(7.2%) and associated with Gr. 1-2 erosive changes in 24 patients (9.6%) and grade 3 in 1 (0.4%); 6Barrett’s esophagus only 10 (7.2%) and associated with Gr. 1-2 
erosive changes in 14 patients (10.1%). GERD: Gastroesophageal reflux disease; PPI: Proton pump inhibitor; IQR: Interquartile range. 
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PPI-medication. None of  the patients used PPI-medi-
cation at three months post-surgery. Barrett’s esophagus 
without erosive changes was observed in 45 patients 3 
mo after surgery and 2 patients had strictures, of  which 
1 was dilated. No cases of  paraesophageal hernia were 
found. The short-term failure rate was similar between 
the two centers and time periods (1.7% vs 1.6%, P = 0.94). 
Two gastric ulcers and one case of  acute gastritis were 
encountered in three patients with ulcer-like dyspepsia 
within 3-5 mo after surgery. All had biopsy-verified He-
licobacter pylori infection and were treated by eradication 
therapy and followed-up by endoscopy and biopsies.
The patients observed typical reflux symptoms, espe-
cially heartburn and regurgitation, changed markedly after 
surgery. While 4 patients were asymptomatic for heart-
burn before and after surgery, 239 patients with reporting 
heartburn preoperatively [98.4% (95%CI: 95.8%-99.5%)] 
were completely symptom free (Figure 1A). Regurgitation 
was ameliorated in 239 [99.2% (97.0%-99.9%)] of  the 
241 patients, while 6 were asymptomatic before and after 
surgery (Figure 1A). Transitory new-onset dysphagia or 
worsening of  preoperative dysphagia within 3 mo after 
surgery was reported by 176 patients (71.3%), but overall, 
dysphagia was significantly reduced from baseline. Dys-
phagia was alleviated in 45 [84.9% (72.4%-92.3%)] of  the 
53 patients having preoperative dysphagia. New onset 
dysphagia (grade 1 in all) was reported by 13 of  the 194 
patients (6.7%) without preoperative dysphagia.
A decreased ability to belch was reported by 164 
[66.4% (60.1%-72.3%)], increased flatulence by 183 
[74.1% (68.2%-79.4%)] and increased bloating by 61 
[24.7% (19.4%-72.3%)] of  the 247 patients. The ability to 
vomit could not be evaluated at three months.
  Variables n  = 249
  Type of surgery
     Floppy Nissen fundoplication       213 (85.5)
     Rosetti-Hell fundoplication         36 (14.5)
     Hiatoplasty       235 (94.4)
  Conversion to open surgery1           7 (2.8)
  Operation time, min, median (IQR)         90 (70.3-135.0)
  Mortality (30 d)           0 (0.0)
  Intraoperative complications           3 (1.2)
     Esophageal perforation           2 (0.8)
     Burn injury of the fundus           1 (0.4) 
  Postoperative morbidity (30 d)2         19 (7.6)
     General         12 (4.8)
        Atelectasis + fever           5 (2.0)
        Pneumonia           7 (2.8)
     Surgical           9 (3.6)
        Pleural empyema           1 (0.4)
        Fundic perforation (burn injury)           1 (0.4)
        Port-site hernia and bowel obstruction           1 (0.4)
        Port-site bleeding           2 (0.8)
        Excessive pain at port-site           1 (0.4)
        Gastric dilatation           1 (0.4)
        Wound infection           1 (0.4)
        Urinary retention           1 (0.4)
  Reoperation rate3           5 (2.0)
     Relaparotomy           4 (1.6)
     Thoracotomy and decortication           1 (0.4)
  Postoperative hospital stay, d, median (IQR)           2 (2-3)
Table 2  Operative data and short-term surgical outcome  n (%)
1Reasons for conversion: intraoperative esophageal perforation (n = 1), 
technical difficulties in dissection (n = 4), obesity (n = 1), problem with CO2-
insufflation (n = 1); 2Figures in the column include some patients with more 
than one complication; 3Reoperations: bowel obstruction (n = 1), fundic 
perforation (n = 1), port-site bleeding (n = 2), thoracotomy and decortica-
tion for pleural empyema (n = 1). IQR: Interquartile range.
Figure 1  Change in point prevalence and severity of typical reflux symp-
toms. A: Patients were assessed for short-term symptoms (n = 247); B: Pa-
tients were assessed for long-term symptoms (n = 139); C: Measurement of 
the changes in long-term moderate to severe symptoms (n = 139). Differences 
between pre- and post-operative symptoms were significant for heartburn and 
regurgitation (P < 0.001), late dysphagia (P = 0.016). FU: Follow-up.
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At their first clinical visit, 235 [95.1% (95%CI: 
92.7%-98.0%)] patients reported better outcome after an-
tireflux surgery than with preoperative medical treatment 
and were willing to have the procedure repeated in situa-
tions similar to preoperative ones.
Long-term outcomes
A cohort of  the first 180 consecutive patients operated 
on between 1992 and 2002 was selected to obtain a me-
dian follow-up time of  10 years until November 2006. 
Of  these, 14 had died of  the following non-gastroesoph-
ageal reflux disease (GERD), related causes: myocardial 
infarctions (n = 3), intoxications (n = 2), cerebral infarc-
tion, pulmonary embolism, aortic rupture, gastric cancer, 
pneumonia, necrotizing fasciitis, chemotherapy-related 
sepsis, cerebral trauma and intracranial hemorrhage, 
and severe myasthenia gravis. In addition, 1 patient had 
severe dementia, 1 had undergone esophageal resection 
for Barrett’s esophagus-related adenocarcinoma, 3 re-
turned incomplete questionnaires, and 22 patients could 
not be contacted, leaving 139 available for evaluation of  
late outcomes [median follow-up time 10.2 years (IQR 
7.2-11.6 years), response rate 85%]. During the long-
term follow-up, 24-h pH monitoring and endoscopy was 
done in 32 patients; 6 showed endoscopically verified 
disrupted fundoplication and pH < 4 median 25.1% (IQR 
13.0%-42.8%) of  total time, and 26 had intact fundopli-
cation and pH median 0.6% (IQR 0.1%-2.4%).
The crude long-term failure rate was 24.5% (34 of  
139 patients): 6 patients (4.3%) underwent reoperation for 
symptomatic and objective recurrence caused by defec-
tive plication, 16 (11.5%) had heartburn, regurgitation, 
dysphagia and PPI medication on a daily/weekly basis, 11 
patients (7.9%) not using PPI medication reported fre-
quent/daily symptoms, and 1 was asymptomatic while on 
medication (Figure 1B and C). The cumulative 5-year fail-
ure rate was 12.3% (95%CI: 7.8%-36.0%) and the 10-year 
failure rate 27.1 % (20.1%-36.0%) (Figure 2), and cure 
rates 87.7% (81.0%-92.2%) and 72.9% (64.0%-79.9%), re-
spectively. One patient underwent a reoperation for para-
esophageal hernia and one for late trocar-site hernia.
Decreased belching ability in the long-term was re-
ported by 61.2% (52.5%-69.3%), increased rectal flatu-
lence by 91.4% (85.4%-95.5%) and bloating by 71.9% 
(63.7%-79.2%). Total inability to vomit was reported by 
43 patients (30.9%).
The mean GSRS score describing overall discomfort 
related to gastrointestinal symptoms was 1.9 (95%CI: 
1.8-2.0) in patients cured by antireflux surgery and 2.8 
(2.4-3.1) in those with failed antireflux surgery (P < 0.001). 
Mean scores for all GSRS dimensions in comparison to a 
healthy control population are shown in Figure 3A. The 
failure of  antireflux surgery and post-fundoplication side 
effects were reflected in the reflux syndrome score and 
indigestion syndrome score. Mean values of  RAND-36 
QoL scores were similar to the scores of  the Finnish age- 
and gender-matched reference population for patients 
without treatment failure but were significantly impaired 
for those with failed antireflux surgery (Figure 3B). 
Long-term outcomes were subjectively graded as 
good as expected (0) by 18.0%, moderately better (+2) 
by 14.4%, markedly better (+3) by 50.4%, and worse (-1) 
5.8%, moderately worse (-2) 8.6% and markedly worse (-3) 
by 2.9%. At the time of  this survey, 118 patients [84.9% 
(95%CI: 77.8%-90.4%)] were willing to undergo surgery 
again under similar preoperative conditions, whereas 21 
patients (15.1%) chose medical treatment as a better ini-
tial treatment option. 
DISCUSSION
Laparoscopic Nissen fundoplication has become the 
method of  choice in antireflux surgery providing good 
short-term outcome in over 90% of  patients, an associ-
ated morbidity rate of  less than 10%, and only a 5% inci-
dence of  new-onset dysphagia[5-10,12,13]. Here, we show that 
laparoscopic Nissen fundoplication effectively abolished 
heartburn and regurgitation, alleviated most preoperative 
dysphagia, and cured erosive esophagitis in most patients 
in the short term. This was achieved with low morbidity, 
a short hospital stay, a low incidence of  new-onset dys-
phagia, and good patient satisfaction, with approximately 
95% of  the patients reporting a better outcome after 
surgery compared with non-surgical medical therapy. 
Mechanical side effects of  total fundoplication may lead 
to a functional obstruction in the gastroesophageal junc-
tion and to an inability to vent air from the stomach[12]. 
As a result, we observed common postoperative side ef-
fects including inability to belch, abdominal bloating, and 
increased flatulence. However, these mild side effects did 
not seem to limit the success of  antireflux surgery. 
Long-term outcomes after laparoscopic antireflux 
surgery in this study were examined in multiple domains 
including symptom response, side effects of  surgery, 
durability of  the antireflux surgery, patient’s subjective 
Figure 2  Cumulative failure rates for laparoscopic Nissen fundoplication. 
Surgical failure is shown as a function of time after median follow-up of 10 years 
(n = 139) (gray part shows 95%CI).
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perception of  the overall success of  the operation, and 
quality of  life. In addition, treatment failure was defined 
according to composite criteria in contrast to previous 
studies[26-30] expressing the clinical outcome as the point 
prevalence of  reflux-associated symptoms and patient 
satisfaction. However, our 5-year (88%) and 10-year (73%) 
cure rates compare well to previous studies reporting 
long-term control of  reflux in 74%-90% of  patients[26-31]. 
Our results also compare well to the nationwide long-
term outcome after laparoscopic antireflux surgery in 
Sweden demonstrating a treatment failure in 25%-29% 
of  the patients[32]. Only one randomized study comparing 
medical and surgical therapies for GERD and including 
patients with good response to PPI therapy, has reported 
similar remission rates at five years (85% vs 92%) between 
laparoscopic antireflux surgery and modern antisecretory 
medication[9]. Similar outcomes after laparoscopic Nissen 
fundoplication were obtained in our study despite the in-
clusion of  patients reporting residual symptoms while on 
medical antisecretory treatment.
Patient well-being or quality of  life are among the 
most important outcome measures in the field of  func-
tional surgery. The GSRS is a useful patient-related scale 
for evaluating the outcome of  treatment for GERD[21]. 
In our study, the GSRS reflected well the long-term suc-
cess of  antireflux surgery as well as the side effects of  
antireflux surgery; it differentiated patients experiencing 
treatment failure from those being cured and from healthy 
controls[22]. Certain side effects, including increased bloat-
ing and rectal flatulence, manifest as indigestion syndrome 
and seem to be inevitable for most patients following fun-
doplication.
Overall quality of  life was evaluated with RAND-36 
(SF-36) because it is well validated in Finnish[23]. Consis-
tent with previous studies[26,30] our results revealed that 
the quality of  life of  patients with long-term treatment 
success is similar to that of  an age- and sex-matched 
general population. On the other hand, failed antireflux 
surgery and symptom recurrence significantly worsened 
quality of  life in most dimensions.
Patients were also given a chance to evaluate the re-
sult of  their surgery in the long-term. Here, 83% of  the 
patients rated their surgical result to be as good as or bet-
ter than expected, while only 17% felt that their surgical 
result was only fair or poor. Similarly, 118 patients (85%) 
were willing to undergo surgery again under similar pre-
operative conditions.
A major challenge with this study and other similar 
studies was its retrospective nature and the lack of  sys-
tematic long-term assessment by endoscopy and ambula-
tory 24-h pH monitoring[31]. The significance of  the use 
of  antireflux medication in the long term is also debat-
able without objective measurements and may not be a 
reliable marker of  surgical failure. On the other hand, we 
used standardized symptom questionnaires, composite 
criteria, and quality of  life assessment to define treatment 
failures. Furthermore, it is the symptom response experi-
enced by patients that ultimately determines the success 
or failure of  antireflux surgery and quality of  life, not the 
change in objective measurements. It is also well known 
that the outcome after antireflux surgery is dependent 
on surgeon’s experience and quality of  the surgery. Sat-
isfactory short-term outcomes indicate, however, that 
the quality of  surgery has been as good in this study as 
elsewhere. The long-term outcome was investigated in 
139 of  the first 180 consecutive patients selected for the 
10-year follow-up. The compliance in this study com-
pares favorably with that in earlier studies with 85% of  
the eligible patients returning the questionnaires for long-
term evaluation.
In the short-term, laparoscopic antireflux surgery 
effectively alleviated symptoms of  gastroesophageal re-
flux disease and cured erosive esophagitis. Postoperative 
adverse effects were usually mild and patient satisfaction 
was good. For the long-term, our results indicate de-
creasing effectiveness of  laparoscopic antireflux surgery, 
although most of  the patients seem to have an overall 
quality of  life similar to that of  the general population.
Figure 3  Comparing successful vs failed laparoscopic Nissen fundopli-
cation by rating common gastrointestinal symptoms. A: Gastrointestinal 
symptom rating scores (GSRS) according to treatment success or failure (dotted 
line = healthy controls[22]); B: RAND-36 scores according to treatment success 
or failure (dotted line = age-matched and sex-matched general population[23]). P 
values were age- and sex-adjusted for treatment success vs failure. 
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COMMENTS
Background
Optimal management of chronic gastroesophageal reflux disease (GERD) is 
uncertain because treatment options can include either modern medical therapy 
that uses proton pump inhibitors or antireflux surgery. 
Research frontiers
Only one randomized study comparing medical and surgical therapies for 
GERD, has reported similar remission rates at 5 years. Data on long-term 
(10-year) cures and quality of life after antireflux surgery vs medical therapy are 
limited.
Innovations and breakthroughs
To assess long-term outcomes, the authors examined several domains affected 
by the operation and defined treatment failures based on composite criteria 
and quality of life assessment. The results show that the excellent short-term 
results after laparoscopic Nissen fundoplication deteriorate over time. Quality of 
life analysis with the Gastrointestinal Symptom Rating Scale reflected well the 
side effects of antireflux surgery and differentiated patients having treatment 
failure from those being cured and from healthy controls. Overall quality of life 
(RAND-36) of patients with long-term treatment success was similar to that of an 
age- and sex-matched general population. Failed antireflux surgery and symp-
tom recurrence significantly worsened the quality of life in most dimensions.
Applications
By defining treatment outcomes with composite criteria and understanding how 
quality of life is affected by failed antireflux surgery, this study represents a 
potential new strategy for assessment of the long-term outcome after antireflux 
surgery.
Peer review
The authors examined the short- and long-term outcome and quality of life after 
laparoscopic fundoplication. By addressing several domains affected by the 
operation and using composite criteria to define treatment failure, they show the 
excellent short-term results after laparoscopic Nissen fundoplication deteriorate 
over time. They also show failed antireflux surgery is associated with reduced 
quality of life. Use of composite criteria and quality of life assessment to define 
treatment failure represents a potential new strategy for the assessment of 
long-term outcomes following antireflux surgery.
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